RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xiangxue Pharmaceutical Co Stock

Xiangxue Pharmaceutical Co Debt 2024

Xiangxue Pharmaceutical Co Debt

2,686.19 CNY

Ticker

300147.SZ

ISIN

CNE100000Y92

In 2024, Xiangxue Pharmaceutical Co's total debt was 2,686.19 CNY, a -7.11% change from the 2,891.65 CNY total debt recorded in the previous year.

Xiangxue Pharmaceutical Co Aktienanalyse

What does Xiangxue Pharmaceutical Co do?

Xiangxue Pharmaceutical Co Ltd is one of the leading companies in the field of traditional Chinese medicine. The company was founded in 1994 and has since undergone impressive development. Originally started as a small company, Xiangxue now has a market share of 10% and is listed on the stock exchange. The company's business model is based on the manufacturing and sale of traditional Chinese medicines. Various herbs and plants are processed into powders, tablets, or liquids and offered in the form of medicines. The application of the products follows the principles of Chinese medicine, which aim to restore the balance between yin and yang in the body. Xiangxue is divided into different divisions to meet the various needs of customers. The largest division is basic care, which focuses on general health care and offers products such as dietary supplements, enzyme preparations, and vitamins. The second division deals with the treatment of digestive system disorders. Here, Xiangxue offers a wide range of products, ranging from the prevention of gastrointestinal complaints to the treatment of conditions such as gastritis and colitis. The third division covers the treatment of respiratory system disorders such as asthma and chronic bronchitis. The company also offers a variety of products in this area, allowing for a broad range of applications. Additionally, there is a division that specializes in the treatment of colds and flu. One of Xiangxue's most famous products is "Shexiang Zhuifeng Gao," a pain-relieving patch. The product has been popular in China and other Asian countries for many years and has also gained international recognition. It is an effective pain relief product that can be used in the treatment of joint pain, back pain, and other pain conditions. In addition to its medicines, Xiangxue also conducts research and development to improve its production processes and active ingredients. The company has a strong research department that focuses on Chinese medicine and collaborates closely with academic institutions and research facilities. Overall, Xiangxue has a strong focus on quality and innovation. The company strives to provide its customers with high-quality products based on traditional Chinese healing methods while also delivering scientific performance. The company is able to meet the high standards of the pharmaceutical industry while maintaining its deep roots in Chinese medicine. Xiangxue understands the needs of its customers and has developed a successful strategy to provide them with the best possible healthcare. The company is an important player in the industry and has earned the respect and loyalty of its customers. Xiangxue Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Xiangxue Pharmaceutical Co's Debt Structure

Xiangxue Pharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Xiangxue Pharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Xiangxue Pharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Xiangxue Pharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Xiangxue Pharmaceutical Co stock

What is the debt of Xiangxue Pharmaceutical Co this year?

Xiangxue Pharmaceutical Co has a debt level of 2,686.19 CNY this year.

What was the debt of Xiangxue Pharmaceutical Co compared to the previous year?

The debt of Xiangxue Pharmaceutical Co has increased by -7.11% compared to the previous year dropped.

What are the consequences of high debt for investors in Xiangxue Pharmaceutical Co?

High debt can pose a risk for investors of Xiangxue Pharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Xiangxue Pharmaceutical Co?

Low debt means that Xiangxue Pharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Xiangxue Pharmaceutical Co affect the company?

An increase in debt of Xiangxue Pharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Xiangxue Pharmaceutical Co affect the company?

A reduction in debt of Xiangxue Pharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Xiangxue Pharmaceutical Co?

Some factors that can influence the debt of Xiangxue Pharmaceutical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Xiangxue Pharmaceutical Co so important for investors?

The debts of Xiangxue Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Xiangxue Pharmaceutical Co take to change the debt?

To change the debt, Xiangxue Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Xiangxue Pharmaceutical Co pay?

Over the past 12 months, Xiangxue Pharmaceutical Co paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 0.38 %. For the coming 12 months, Xiangxue Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Xiangxue Pharmaceutical Co?

The current dividend yield of Xiangxue Pharmaceutical Co is 0.38 %.

When does Xiangxue Pharmaceutical Co pay dividends?

Xiangxue Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, September, July.

How secure is the dividend of Xiangxue Pharmaceutical Co?

Xiangxue Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Xiangxue Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xiangxue Pharmaceutical Co located?

Xiangxue Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xiangxue Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xiangxue Pharmaceutical Co from 6/23/2020 amounting to 0.046 CNY, you needed to have the stock in your portfolio before the ex-date on 6/23/2020.

When did Xiangxue Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/23/2020.

What was the dividend of Xiangxue Pharmaceutical Co in the year 2023?

In the year 2023, Xiangxue Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Xiangxue Pharmaceutical Co pay out the dividend?

The dividends of Xiangxue Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xiangxue Pharmaceutical Co

Our stock analysis for Xiangxue Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xiangxue Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.